- Home
- Publications
- Publication Search
- Publication Details
Title
2023 Chinese guideline for lipid management
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-08-30
DOI
10.3389/fphar.2023.1190934
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statin Use in Pregnancy: Is It Time For a Paradigm Shift?
- (2022) Rina Mauricio et al. CIRCULATION
- Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels
- (2022) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk
- (2022) Anurag Mehta et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment
- (2022) Paula Byrne et al. JAMA Internal Medicine
- Effects of Cuisine-Based Chinese Heart-Healthy Diet in Lowering Blood Pressure Among Adults in China: Multicenter, Single-Blind, Randomized, Parallel Controlled Feeding Trial
- (2022) Yanfang Wang et al. CIRCULATION
- Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
- (2022) Byeong-Keuk Kim et al. LANCET
- Efficacy and safety of hybutimibe in combination with atorvastatin for treatment of hypercholesteremia among patients with atherosclerotic cardiovascular disease risk equivalent: A multicenter, randomized, double-blinded phase III study
- (2022) Litong Qi et al. Frontiers in Cardiovascular Medicine
- Low-density lipoprotein cholesterol in oldest old with acute myocardial infarction: Is lower the better?
- (2022) Hui-Hui Liu et al. AGE AND AGEING
- Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
- (2022) Michelle L. O’Donoghue et al. CIRCULATION
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
- (2022) Aruna Das Pradhan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of a randomized control trial and an observational biomarker study
- (2022) Yuji Nishizaki et al. AMERICAN HEART JOURNAL
- Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors
- (2021) Kwok Leung Ong et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Fetal toxicity associated with statins: A systematic review and meta-analysis
- (2021) Amir Vahedian-Azimi et al. ATHEROSCLEROSIS
- A systematic review and meta-analysis on the effects of statins on pregnancy outcomes
- (2021) Amir Vahedian-Azimi et al. ATHEROSCLEROSIS
- Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia
- (2021) Moritz Döbert et al. CIRCULATION
- Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement
- (2021) Maria Donata Di Taranto et al. CLINICAL GENETICS
- Triglycerides and Residual Atherosclerotic Risk
- (2021) Sergio Raposeiras-Roubin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacokinetic Study of Oral 14C-Radiolabeled Hyzetimibe, A New Cholesterol Absorption Inhibitor
- (2021) Jianwei Liao et al. Frontiers in Pharmacology
- A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia
- (2021) Maged M. Costantine et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Left ventricular and atrial remodelling in hypertensive patients using thresholds from international guidelines and EMINCA data
- (2021) Yuanyuan Sheng et al. European Heart Journal-Cardiovascular Imaging
- The clinical effect of Xuezhikang combined with ezetimibe in the treatment of coronary heart disease in lipid-lowering treatment and its influence on blood lipid level
- (2021) Liling GUO et al. PANMINERVA MEDICA
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
- (2020) Jan Borén et al. EUROPEAN HEART JOURNAL
- Prognostic value of left ventricular hypertrophy in hypertensive patients: A meta‐analysis of electrocardiographic studies
- (2020) Hongsheng Zhang et al. Journal of Clinical Hypertension
- Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
- (2020) Sotirios Tsimikas et al. NEW ENGLAND JOURNAL OF MEDICINE
- LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial
- (2020) Peter Sever et al. European Journal of Preventive Cardiology
- Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association
- (2020) Laxmi S. Mehta et al. CIRCULATION
- Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease
- (2020) Alan Chait et al. DIABETES
- Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects
- (2020) Jian-Jun Li et al. Expert Opinion on Drug Metabolism & Toxicology
- Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial
- (2020) Rafael Diaz et al. European Journal of Preventive Cardiology
- Evinacumab for Homozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia
- (2020) Gerald F. Watts et al. Heart Lung and Circulation
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk
- (2019) Seohyuk Lee et al. European Journal of Preventive Cardiology
- Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
- (2019) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
- (2019) Jane Armitage et al. LANCET
- Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality
- (2019) Victor W. Zhong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomised study of Evolocumab in Patients With Type 2 Diabetes and Dyslipidaemia on Background Statin: Pre-Specified Analysis of the China Population From the BERSON Clinical Trial
- (2019) Yundai Chen et al. DIABETES OBESITY & METABOLISM
- Use of lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. Don P. Wilson, MD, on behalf of the Writing group
- (2019) Don P. Wilson et al. Journal of Clinical Lipidology
- Clinical Practice Recommendations for Pediatric Dyslipidemia
- (2019) Casey Elkins et al. Journal of Pediatric Health Care
- A Novel Modified System of Simplified Chinese Criteria for Familial Hypercholesterolemia (SCCFH)
- (2019) Ye-Xuan Cao et al. Molecular Diagnosis & Therapy
- Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older
- (2019) Richard G. Bach et al. JAMA Cardiology
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
- (2019) Ann C. Skulas-Ray et al. CIRCULATION
- Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75)
- (2019) Yasuyoshi Ouchi et al. CIRCULATION
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
- (2019) Joseph L. Witztum et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of care
- (2019) Uma Ramaswami et al. ATHEROSCLEROSIS
- Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease
- (2019) Anne C. Goldberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ODYSSEY EAST: Alirocumab efficacy and safety vs ezetimibe in high cardiovascular risk patients with hypercholesterolemia and on maximally tolerated statin in China, India, and Thailand
- (2019) Yaling Han et al. Journal of Clinical Lipidology
- 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
- (2019) Ilse K. Luirink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Marine Omega‐3 Supplementation and Cardiovascular Disease: An Updated Meta‐Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants
- (2019) Yang Hu et al. Journal of the American Heart Association
- HEART UK consensus statement on Lipoprotein(a): A call to action
- (2019) Jaimini Cegla et al. ATHEROSCLEROSIS
- Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
- (2018) Christie M. Ballantyne et al. ATHEROSCLEROSIS
- Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial
- (2018) Antonio J. Vallejo-Vaz et al. CIRCULATION
- Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: An Analysis from FOURIER
- (2018) Marc S. Sabatine et al. CIRCULATION
- Role of Anti-PCSK9 Antibodies in the Treatment of Patients with Statin Intolerance
- (2018) Julia Schreml et al. CURRENT MEDICINAL CHEMISTRY
- Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults
- (2018) Mei Zhang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering
- (2018) Eliano P. Navarese et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Guidance for Pediatric Familial Hypercholesterolemia 2017
- (2018) Mariko Harada-Shiba et al. Journal of Atherosclerosis and Thrombosis
- Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
- (2018) Mariko Harada-Shiba et al. Journal of Atherosclerosis and Thrombosis
- A Meta-Analysis of the Effect of PCSK9-Monoclonal Antibodies on Circulating Lipoprotein (a) Levels
- (2018) Ye-Xuan Cao et al. American Journal of Cardiovascular Drugs
- Familial hypercholesterolemia treatments: Guidelines and new therapies
- (2018) Frederick J. Raal et al. ATHEROSCLEROSIS
- Non-high-density lipoprotein cholesterol and risk of cardiovascular disease in the general population and patients with type 2 diabetes: A systematic review and meta-analysis
- (2018) Yanchao Cao et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation
- (2018) Di Sun et al. Lipids in Health and Disease
- Epidemiology of cardiovascular disease in China: current features and implications
- (2018) Dong Zhao et al. Nature Reviews Cardiology
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liver Transplantation for Homozygous Familial Hypercholesterolemia
- (2018) Yasushi Ishigaki et al. Journal of Atherosclerosis and Thrombosis
- Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study
- (2017) Christian M Madsen et al. EUROPEAN HEART JOURNAL
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
- (2017) Erin A. Bohula et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Zhibitai and low-dose atorvastatin reduce blood lipids and inflammation in patients with coronary artery disease
- (2017) Yuhong Zhao et al. MEDICINE
- Cognitive Function in a Randomized Trial of Evolocumab
- (2017) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
- (2017) Kevin Fitzgerald et al. NEW ENGLAND JOURNAL OF MEDICINE
- A systematic review of the effect of dietary saturated and polyunsaturated fat on heart disease
- (2017) P.M. Clifton et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Efficacy and safety of Zhibitai in combination with atorvastatin for lipid lowering in patients with coronary heart disease
- (2017) Danyan Xu et al. Oncotarget
- Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes
- (2017) Marshall B. Elam et al. JAMA Cardiology
- Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor)
- (2017) Aurélie Thedrez et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- 2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?
- (2016) Sripal Bangalore et al. AMERICAN JOURNAL OF MEDICINE
- The prevalence, awareness, treatment and control of dyslipidemia among adults in China
- (2016) Ling Pan et al. ATHEROSCLEROSIS
- Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese PopulationClinical Perspective
- (2016) Xueli Yang et al. CIRCULATION
- Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association
- (2016) Barbara S. Wiggins et al. CIRCULATION
- Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationClinical Perspective
- (2016) Lotte Kaasenbrood et al. CIRCULATION
- Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular DiseaseCLINICAL PERSPECTIVE
- (2016) Michael J. Blaha et al. CIRCULATION
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- (2016) Børge G. Nordestgaard CIRCULATION RESEARCH
- Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents
- (2016) Paul M Ridker et al. EUROPEAN HEART JOURNAL
- Cardiovascular risk stratification in familial hypercholesterolaemia
- (2016) Mahtab Sharifi et al. HEART
- Efficacy and safety of fenofibrate as an add-on in patients with elevated triglyceride despite receiving statin treatment
- (2016) Shuiping Zhao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
- (2016) Michael G. Silverman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 10-Year Trends in Serum Lipid Levels and Dyslipidemia Among Children and Adolescents From Several Schools in Beijing, China
- (2016) Wenqing Ding et al. JOURNAL OF EPIDEMIOLOGY
- Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment
- (2016) Joseph Yeboah et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
- (2016) Salim Yusuf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
- (2016) Salim Yusuf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
- (2016) Lancet Diabetes & Endocrinology
- IMPROVE-IT clinical implications. Should the “high-intensity cholesterol-lowering therapy” strategy replace the “high-intensity statin therapy”?
- (2015) Luis Masana et al. ATHEROSCLEROSIS
- Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes
- (2015) Antonio J. Vallejo-Vaz et al. ATHEROSCLEROSIS
- Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany
- (2015) Franz Heigl et al. ATHEROSCLEROSIS SUPPLEMENTS
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- High-density lipoprotein subfractions in relation with the severity of coronary artery disease: A Gensini score assessment
- (2015) Rui-Xia Xu et al. Journal of Clinical Lipidology
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
- (2015) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
- (2015) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
- (2015) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
- (2015) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simultaneous determination of hyzetimibe and its main active metabolite in plasma by LC–MS/MS and its application in PK study
- (2015) Jinliang Chen et al. Bioanalysis
- Meta-Analysis of the Effect of Statins on Renal Function
- (2014) Qiang Geng et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials)
- (2014) Daniel Gaudet et al. AMERICAN JOURNAL OF CARDIOLOGY
- The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial
- (2014) Shui-ping Zhao et al. ATHEROSCLEROSIS
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- (2014) M. Cuchel et al. EUROPEAN HEART JOURNAL
- Safety and tolerability of injectable lipid-lowering drugs: a review of available clinical data
- (2014) Arrigo FG Cicero et al. Expert Opinion On Drug Safety
- An assessment by the Statin Liver Safety Task Force: 2014 update
- (2014) Harold Bays et al. Journal of Clinical Lipidology
- An assessment by the Statin Diabetes Safety Task Force: 2014 update
- (2014) Kevin C. Maki et al. Journal of Clinical Lipidology
- Pharmacokinetics, pharmacodynamics, safety, and tolerability of hyzetimibe (HS-25) in healthy Chinese subjects
- (2014) Zhourong Ruan et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)
- (2014) Peter Willeit et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Relations of Change in Plasma Levels of LDL‐C, Non‐HDL‐C and apoB With Risk Reduction From Statin Therapy: A Meta‐Analysis of Randomized Trials
- (2014) George Thanassoulis et al. Journal of the American Heart Association
- Targeting PCSK9 for Hypercholesterolemia
- (2013) Giuseppe Danilo Norata et al. Annual Review of Pharmacology and Toxicology
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia
- (2013) Scott M. Grundy Journal of Clinical Lipidology
- Discovery and refinement of loci associated with lipid levels
- (2013) Cristen J Willer et al. NATURE GENETICS
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials
- (2012) Doralisa Morrone et al. ATHEROSCLEROSIS
- Serum Lipids and Lipoproteins in Chinese Men and Women
- (2012) Wenying Yang et al. CIRCULATION
- Lipid-Related Markers and Cardiovascular Disease Prediction
- (2012) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia
- (2012) Jennifer B. Christian et al. Journal of Clinical Lipidology
- Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial
- (2012) Gregory C. Shearer et al. JOURNAL OF LIPID RESEARCH
- The Current State of Niacin in Cardiovascular Disease Prevention
- (2012) Paul M. Lavigne et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Similarities and differences between the effects of EPA and DHA on markers of atherosclerosis in human subjects
- (2012) Darshan S. Kelley et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Statin Therapy and the Risk of Intracerebral Hemorrhage
- (2012) James S. McKinney et al. STROKE
- Statins and Intracerebral Hemorrhage
- (2011) Daniel G. Hackam et al. CIRCULATION
- A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
- (2011) Allan D. Sniderman et al.
- Impact of 10mg rosuvastatin daily or alternate-day on lipid profile and inflammatory markers
- (2011) Jian-Jun Li et al. CLINICA CHIMICA ACTA
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Combination of carotid intima-media thickness and plaque for better predicting risk of ischaemic cardiovascular events
- (2011) W. Xie et al. HEART
- Long-Term Probucol Treatment Prevents Secondary Cardiovascular Events: a Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan
- (2011) Shizuya Yamashita et al. Journal of Atherosclerosis and Thrombosis
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
- (2010) SHARP Collaborative Group AMERICAN HEART JOURNAL
- Lipid-Lowering Efficacy of Red Yeast Rice in a Population Intolerant to Statins
- (2010) Carmelo V. Venero et al. AMERICAN JOURNAL OF CARDIOLOGY
- Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)
- (2010) Jian-Jun Li et al. ANNALS OF MEDICINE
- Evaluation of the lipid lowering ability, anti-inflammatory effects and clinical safety of intensive therapy with Zhibitai, a Chinese traditional medicine
- (2010) Dan-yan Xu et al. ATHEROSCLEROSIS
- Future Cardiovascular Disease in China
- (2010) Andrew Moran et al.
- Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
- (2010) Frederick J Raal et al. LANCET
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2010) Dariush Mozaffarian et al. PLOS MEDICINE
- Health effects of trans-fatty acids: experimental and observational evidence
- (2009) D Mozaffarian et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prescription Omega-3 Fatty Acid as an Adjunct to Fenofibrate Therapy in Hypertriglyceridemic Subjects
- (2009) Eli M Roth et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
- (2009) Pierre Amarenco et al. LANCET NEUROLOGY
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction
- (2008) Zongliang Lu et al. AMERICAN JOURNAL OF CARDIOLOGY
- Egg Consumption and Risk of Type 2 Diabetes in Men and Women
- (2008) L. Djousse et al. DIABETES CARE
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started